Spanberger Seeks Additional Answers from DEA, FDA on Efforts to Stop Ongoing ADHD Medication Shortages
WASHINGTON, D.C. — U.S. Representative Abigail Spanberger is urging the Drug Enforcement Administration (DEA) and Food and Drug Administration (FDA) to provide additional answers on their work to end shortages of attention deficit hyperactivity disorder (ADHD) medications — including Adderall.
Other Articles in this Edition
‘Amazing Race’ Winner Penn Holderness Aims To Change Stereotypes About ADHD
Some people with ADHD thrive in periods of stress, new study shows
Cooking With A.D.H.D. Can Be Overwhelming. These Cooks Are Finding Ways to Thrive.
Pentagon expands list of medical conditions that no longer disqualify enlistment in armed forces
How fidgeting can help people with ADHD focus
Putting community first: ADHD program challenges traditional research paradigms
Experts urge tailored perinatal care for neurodivergent mothers
Why so many people with ADHD are breaking free from gender norms
Digame: Sara Mendez is Advocating for BIPOC with ADHD
ADHD: Overlooked Cause of Persistent Anxiety and Depression in Adults